Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2
Article in Chemical Communications (April 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Article in Chemical Communications (April 2024)
Book chapter (January 2024)
Article in Frontiers in Immunology (May 2023)